Survey of medical university staff: assessment of COVID-19 manifestations in periods of peak and convalescence


The aim of the study was to assess the frequency of symptoms of post-COVID syndrome by means of a questionnaire among medical university employees.

Material and methods. From March 2021 to February 2022, an anonymous online survey was conducted at the A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation. Only 313 fully completed questionnaires were selected for analysis.

Results and discussion. A wide range of asthenic, infectious-inflammatory, respiratory, cardiovascular, neuropsychiatric, gastroenterological and dermatological symptoms were noted both during the peak period and during the convalescence of COVID-19. According to the subjective data of respondents, for more than 3 months, various symptoms associated with deterioration of health after recovering from a new coronavirus infection persisted in 25.9% of cases. Within 3–6 months after the illness and more than 6 months, 44.6% and 55.4% of respondents noted the presence of symptoms of post-COVID syndrome, respectively. During the analysis, it was found that with an increase in the volume of lung damage according to CT data, there was a tendency to increase the proportion of respondents with a long-term (more than 6 months) persistent symptoms of post-COVID syndrome from 20% with CT score 0, up to 29% with CT score 1–2 and up to 58% with CT score 3–4. In this regard, apparently, it is necessary to develop additional screening programs as part of the medical examination of COVID-19 patients.

Conclusion. SARS-CoV-2 infection causes a wide range of symptoms both during the period of the disease and during the period of convalescence. Attention should be paid to the need for a targeted survey of patients who have undergone COVID-19 to identify the manifestations of post-COVID syndrome and conduct their medical examination with the participation of a multidisciplinary team.

Keywords:post-COVID syndrome; COVID-19; SARS-CoV-2

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

Contribution. The authors contributed equally to this article.

For citation: Yanushevich O.O., Yushchuk E.N., Smetneva N.S., Levchenko O.V., Machulina A.I. Survey of medical university staff: assessment of COVID-19 manifestations in periods of peak and convalescence. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2022; 11 (3): 12–20. DOI:


1. L’vov D.K., Al’khovsky S.V. Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus). Voprosy virusologii [Problems of Virology]. 2020; 65 (2): 62–70. DOI: (in Russian)

2. Tansey Catherine M., et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007; 167 (12): 1312–20

3. Menni C., et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022; 399 (10 335): 1618–24.

4. Sudre C.H., et al. Attributes and predictors of long COVID. Nat Med. 2021; 27 (4): 626–31.

5. Taquet M., et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021; 18 (9): e1003773.

6. Zvegintseva A.A., et al. Neurological aspects of COVID-19. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2021; 20 (S1): 34–5. DOI: (in Russian)

7. Malykhin F.T. COVID-19 in medical students: acute phase clinical manifestations and post-COVID syndrome. Mezhdunarodniy zhurnal sedtsa i sosudistykh zabolevaniy [International Journal of Heart and Vascular Diseases]. 2022; 10 (33.1): 38–43. DOI: (in Russian)

8. URL:

9. Karpova L.S., Stolyarov K.A., Popovtseva N.M., Stolyarova T.P., Danilenko D.M. Comparison of the first three waves of the COVID-19 pandemic in Russia in 2020–21. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2022; 21 (2): 4–16. DOI: (in Russian)

10. URL: https://xn--80aesfpebagmfblc0a.xn--p1ai/

11. URL:

12. Zayrat’yants O.V., Samsonova M.V., Chernyaev A.L., et al. COVID-19 pathology: experience of 2000 autopsies. Sudebnaya meditsina [Forensic Medicine]. 2020; 6 (4): 10–23. DOI: (in Russian)

13. Golovacheva V.A., Tabeeva G.R., Kuznetsov I.V. Cognitive disorders in COVID-19: interrelation, pathogenesis and questions of therapy. Nevrologiya, neyropsikhiatriya, psikhosomatika [Neurology, Neuropsychiatry, Psychosomatics]. 2021; 13 (2): 123–9. (in Russian)

14. Modjtahedi B.S., et al. Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis. JAMA Ophthalmol. 2022; 140 (5): 523–7.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»